Table 4 Comparison of performance measures among the NPI ∗ , the baseline, and ad hoc NPI strategy using results from the 2-level experiment with the low transmissibility scenario
From: Design of non-pharmaceutical intervention strategies for pandemic influenza outbreaks
Performance measure | Baseline | NPI | NPI∗ | Performance measure | Baseline | NPI | NPI* |
|---|---|---|---|---|---|---|---|
IAR | 33.06% | 20.62% | 1.83% | Infections 0-19 yrs. | 225,467 | 156,849 | 14,345 |
CFR | 0.69% | 0.37% | 0.03% | Infections 20-64 yrs. | 91,959 | 43,135 | 3,346 |
Pandemic Duration (Days) | 135 | 350 | 75 | Infections 65-99 yrs. | 17,645 | 8,975 | 857 |
Total Contacts | 1,177,393 | 738,716 | 71,771 | Infections Households | 37,562 | 65,107 | 7,470 |
Contacts 0-19 yrs. | 818,912 | 618,661 | 62,920 | Infect. MG Types(1-2) | 46,600 | 7,019 | 535 |
Contacts 20-64 yrs. | 294,046 | 102,973 | 7,160 | Infect. Schools | 249,304 | 136,043 | 10,458 |
Contacts 65-99 yrs. | 64,435 | 17,082 | 1,691 | Infect. MG Types(9-12) | 1,605 | 790 | 85 |
Contacts Households | 238,684 | 344,169 | 40,213 | Total Deaths | 7,009 | 3,764 | 303 |
Contacts MG Types(1-2) | 231,051 | 37,785 | 3,185 | Deaths 0-19 yrs. | 1,041 | 744 | 67 |
Contacts Schools | 699,427 | 352,987 | 28,013 | Deaths 20-64 yrs. | 4,095 | 2,059 | 156 |
Contacts MG Types(9-12) | 8,231 | 3,775 | 360 | Deaths 65-99 yrs. | 1,873 | 961 | 80 |
Total Infections | 335,071 | 208,959 | 18,548 |